MYC controls metastatic heterogeneity in pancreatic cancer
R. Maddipati, R. Norgard, T. Baslan, K. Rathi, A. Zhang, P. Raman, J. Pitarresi, M. Wengyn, T. Yamazoe, J. Li, D. Balli, M. LaRiviere, I. Folkert, I. Millstein, J. Bermeo, , B. Stanger
This study identifies MYC as a key driver of metastatic heterogeneity in pancreatic cancer by linking its activity to increased metastasis through TAM recruitment.
bioRxiv · Jan 30, 2021 · PreprintCancer Biology